NASDAQ : LONA
LeonaBio, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 4.94 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 46.54M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 21.27M | 16.68M | 26.09M | 33.30M | 32.55M | 21.23M |
| Research & Development | 33.50M | 17.50M | 70.68M | 93.79M | 61.46M | 42.79M |
| Operating Expenses | 54.77M | 34.18M | 96.78M | 127.09M | 94.02M | 64.02M |
| Operating Income | -54.77M | -34.18M | -96.78M | -127.09M | -94.02M | -64.02M |
| Other Non Operating Income (Expenses) | -19.22M | -3.67M | 3.45M | 6.38M | 7.96M | 9.17M |
| EBT Excluding Unusual Items | -73.99M | -37.85M | -93.33M | -120.71M | -86.06M | -54.85M |
| Gain (Loss) on Sale of Investments | 625.00K | 329.00K | 515.00K | 1.41M | 422.00K | |
| Legal Settlements | -4.13M | -10.00M | ||||
| Pretax Income | -141.46M | -105.61M | -96.94M | -117.67M | -95.64M | -54.85M |
| Net Income | -141.46M | -105.61M | -96.94M | -117.67M | -95.64M | -54.85M |
| Net Income to Common | -141.46M | -105.61M | -96.94M | -117.67M | -95.64M | -54.85M |
| Shares Outstanding (Basic) | 13.01M | 4.28M | 3.85M | 3.80M | 3.77M | 3.69M |
| Shares Outstanding (Diluted) | 13.01M | 4.28M | 3.85M | 3.80M | 3.77M | 3.69M |
| EPS (Basic) | -10.88 | -24.70 | -25.19 | -30.95 | -25.35 | -14.86 |
| EPS (Diluted) | -10.88 | -24.70 | -25.19 | -30.95 | -25.35 | -14.86 |
| Free Cash Flow | -61.93M | -45.73M | -97.20M | -101.06M | -73.61M | -44.67M |
| Free Cash Flow Per Share | -4.76 | -10.70 | -25.26 | -26.58 | -19.51 | -12.10 |
| EBITDA | -53.83M | -33.21M | -95.81M | -126.12M | -93.17M | -63.54M |
| D&A For EBITDA | 944.00K | 972.00K | 970.00K | 969.00K | 845.00K | 479.00K |
| EBIT | -54.77M | -34.18M | -96.78M | -127.09M | -94.02M | -64.02M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 32.32M | 69.28M | 48.44M | 90.58M | 95.97M | 110.54M |
| Short-Term Investments | 18.74M | 19.05M | 2.84M | 56.84M | 104.38M | 143.22M |
| Cash & Short-Term Investments | 51.07M | 88.33M | 51.27M | 147.42M | 200.34M | 253.76M |
| Accounts Receivable | 1.23M | 2.34M | ||||
| Other Receivables | 1.63M | |||||
| Receivables | 1.63M | 1.23M | 2.34M | |||
| Prepaid Expenses | 3.74M | 1.13M | 3.57M | 5.68M | 5.96M | 4.70M |
| Total Current Assets | 54.81M | 89.46M | 54.84M | 154.73M | 207.53M | 260.80M |
| Property, Plant & Equipment | 1.40M | 2.01M | 3.25M | 4.44M | 5.32M | 5.22M |
| Long-Term Investments | 44.83M | 65.94M | ||||
| Other Long-Term Assets | 686.00K | 686.00K | 686.00K | 1.08M | 475.00K | 56.00K |
| Total Assets | 56.89M | 92.15M | 58.78M | 160.25M | 258.15M | 332.01M |
| Accounts Payable | 2.42M | 4.59M | 319.00K | 129.00K | 2.50M | 567.00K |
| Accrued Expenses | 4.91M | 4.96M | 12.40M | 28.34M | 18.60M | 8.44M |
| Current Portion of Leases | 491.00K | 465.00K | 414.00K | 368.00K | 326.00K | 288.00K |
| Other Current Liabilities | 37.49M | |||||
| Total Current Liabilities | 7.82M | 47.50M | 13.13M | 28.84M | 21.43M | 9.29M |
| Long-Term Leases | 86.00K | 338.00K | 803.00K | 1.22M | 1.58M | 1.63M |
| Other Long-Term Liabilities | 15.40M | 16.52M | ||||
| Total Liabilities | 23.30M | 64.36M | 13.94M | 30.06M | 23.02M | 10.92M |
| Common Stock | 1.00K | 1.00K | 4.00K | 4.00K | 4.00K | |
| Additional Paid-In Capital | 597.31M | 539.55M | 450.99M | 439.74M | 428.62M | 417.36M |
| Retained Earnings | -563.71M | -511.75M | -406.15M | -309.21M | -191.53M | -95.89M |
| Comprehensive Income & Other | -9.00K | -4.00K | 1.00K | -349.00K | -1.96M | -388.00K |
| Total Common Equity | 33.59M | 27.79M | 44.84M | 130.19M | 235.14M | 321.08M |
| Shareholders' Equity | 33.59M | 27.79M | 44.84M | 130.19M | 235.14M | 321.08M |
| Total Liabilities & Equity | 56.89M | 92.15M | 58.78M | 160.25M | 258.15M | 332.01M |
| Total Debt | 577.00K | 803.00K | 1.22M | 1.58M | 1.91M | 1.92M |
| Net Cash (Debt) | 50.49M | 87.53M | 50.06M | 145.83M | 198.43M | 251.84M |
| Net Cash Per Share | 3.88 | 20.47 | 13.01 | 38.36 | 52.59 | 68.21 |
| Filing Date Shares Outstanding | 9.42M | 9.39M | 3.90M | 3.83M | 3.79M | 3.76M |
| Total Common Shares Outstanding | 9.42M | 9.34M | 3.90M | 3.82M | 3.79M | 3.74M |
| Working Capital | 46.99M | 41.95M | 41.71M | 125.89M | 186.10M | 251.51M |
| Book Value Per Share | 3.57 | 2.98 | 11.49 | 34.11 | 62.08 | 85.90 |
| Tangible Book Value | 33.59M | 27.79M | 44.84M | 130.19M | 235.14M | 321.08M |
| Tangible Book Value Per Share | 3.57 | 2.98 | 11.49 | 34.11 | 62.08 | 85.90 |
| Machinery | 1.42M | 1.42M | 1.42M | 1.40M | 1.12M | 593.00K |
| Construction In Progress | 1.12M | |||||
| Leasehold Improvements | 4.32M | 4.32M | 4.32M | 4.32M | 4.30M | 2.56M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -141.46M | -105.61M | -96.94M | -117.67M | -95.64M | -54.85M |
| Depreciation & Amortization | 944.00K | 972.00K | 970.00K | 969.00K | 845.00K | 479.00K |
| Loss (Gain) From Sale of Assets | 7.00K | |||||
| Asset Writedown & Restructuring Costs | 67.66M | 67.66M | ||||
| Loss (Gain) From Sale of Investments | -625.00K | -329.00K | -515.00K | -1.41M | -422.00K | 493.00K |
| Stock-Based Compensation | 6.71M | 6.10M | 11.05M | 10.62M | 10.61M | 4.62M |
| Other Operating Activities | 20.43M | 4.85M | 241.00K | 214.00K | 203.00K | 155.00K |
| Change in Accounts Receivable | 1.23M | 1.11M | -1.04M | |||
| Change in Accounts Payable | -13.39M | -21.34M | -5.75M | 7.37M | 2.10M | 5.15M |
| Change in Other Net Operating Assets | -2.21M | 1.97M | -6.23M | -2.07M | 8.73M | 1.89M |
| Operating Cash Flow | -61.93M | -45.73M | -97.17M | -100.75M | -72.47M | -43.10M |
| Capital Expenditures | -33.00K | -304.00K | -1.14M | -1.57M | ||
| Investment in Securities | -8.19M | -15.89M | 54.86M | 95.39M | 58.80M | -2.51M |
| Investing Cash Flow | -8.19M | -15.89M | 54.83M | 95.09M | 57.66M | -4.08M |
| Issuance of Common Stock | 90.12M | 90.03M | 194.00K | 493.00K | 654.00K | 97.09M |
| Other Financing Activities | -7.57M | -7.57M | ||||
| Financing Cash Flow | 82.55M | 82.46M | 194.00K | 493.00K | 654.00K | 97.09M |
| Net Cash Flow | 12.44M | 20.84M | -42.15M | -5.17M | -14.15M | 49.91M |
| Free Cash Flow | -61.93M | -45.73M | -97.20M | -101.06M | -73.61M | -44.67M |
| Free Cash Flow Per Share | -4.76 | -10.70 | -25.26 | -26.58 | -19.51 | -12.10 |
| Levered Free Cash Flow | -23.14M | 22.47M | -60.51M | -60.90M | -36.50M | -31.15M |
| Unlevered Free Cash Flow | -23.14M | 22.47M | -60.51M | -60.90M | -36.50M | -31.15M |
| Change in Working Capital | -15.60M | -19.38M | -11.98M | 6.53M | 11.94M | 6.00M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 44.56M | 29.86M | 22.69M | 92.47M | 119.92M | 486.68M |
| Enterprise Value | -5.93M | 5.54M | -44.85M | -78.80M | -99.06M | 252.90M |
| Last Close Price | 4.73 | 7.57 | 5.87 | 24.30 | 31.70 | 130.30 |
| PB Ratio | 1.33 | 1.07 | 0.51 | 0.71 | 0.51 | 1.52 |
| P/TBV Ratio | 1.33 | 1.07 | 0.51 | 0.71 | 0.51 | 1.52 |
| Debt / Equity Ratio | 0.02 | 0.03 | 0.03 | 0.01 | 0.01 | 0.01 |
| Net Debt / Equity Ratio | -1.50 | -3.15 | -1.12 | -1.12 | -0.84 | -0.78 |
| Net Debt / EBITDA Ratio | 0.94 | 2.64 | 0.52 | 1.16 | 2.13 | 3.96 |
| Net Debt / FCF Ratio | 0.81 | 1.91 | 0.52 | 1.44 | 2.70 | 5.64 |
| Quick Ratio | 6.53 | 1.86 | 3.90 | 5.17 | 9.41 | 27.56 |
| Current Ratio | 7.01 | 1.88 | 4.17 | 5.37 | 9.68 | 28.07 |
| Return on Equity (ROE) | -431.39% | -290.81% | -110.77% | -64.42% | -34.39% | -18.43% |
| Return on Assets (ROA) | -74.06% | -28.31% | -55.23% | -37.97% | -19.91% | -13.08% |
| Return on Capital Employed (ROCE) | -111.60% | -76.50% | -212.00% | -96.70% | -39.70% | -19.80% |
| Earnings Yield | -229.96% | -353.74% | -427.29% | -127.25% | -79.75% | -11.27% |
| FCF Yield | -138.96% | -153.17% | -428.45% | -109.28% | -61.38% | -9.18% |
| Buyback Yield / Dilution | -233.81% | -11.12% | -1.21% | -0.76% | -2.20% | -208.53% |